ArticleMolecular therapy oncolytics2022

Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells.

Chao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.